Summary
We have explored the role of excitatory amino acids in the increased dopamine (DA) release that occurs in the neostriatum during stress-induced behavioral activation. Studies were performed in awake, freely moving rats, usingin vivo microdialysis. Extracellular DA was used as a measure of DA release; extracellular 3,4-dihydroxyphenylalanine (DOPA) after inhibition of DOPA decarboxylase provided a measure of apparent DA synthesis. Mild stress increased the synthesis and release of DA in striatum. DA synthesis and release also were enhanced by the intra-striatal infusion of N-methyl-D-aspartate (NMDA), an agonist at NMDA receptors, and kainic acid, an agonist at the DL-a-amino-3-hydroxy-5-methyl-4-isoxazole-4-propionate (AMPA)/kainate site. Stress-induced increase in DAsynthesis was attenuated by co-infusion of 2-amino-5-phosphonovalerate (APV) or 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), antagonists of NMDA and AMPA/kainate receptors, respectively. In contrast, intrastriatal APV, CNQX, or kynurenic acid (a non-selective ionotropic glutamate receptor antagonist) did not block the stress-induced increase in DArelease. Stress-induced increase in DA release was, however, blocked by administration of tetrodotoxin along the nigrostriatal DA projection. It also was attenuated when APV was infused into substantia nigra. Thus, glutamate may act via ionotropic receptors within striatum to regulate DA synthesis, whereas glutamate may influence DA release via an action on receptors in substantia nigra. However, our method for monitoring DA synthesis lowers extracellular DA and this may permit the appearance of an intra-striatal glutamatergic influence by reducing a local inhibitory influence of DA. If so, under conditions of low extracellular DA glutamate may influence DA release, as well as DA synthesis, by an intrastriatal action. Such conditions might occur during prolonged severe stress and/or DA neuron degeneration. These results may have implications for the impact of glutamate antagonists on the ability of patients with Parkinson's disease to tolerate stress.
Similar content being viewed by others
References
Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ (1989) Differential effect of stress onin vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52: 1655–1658
Carter CJ, L'Heureux R, Scatton B (1988) Differential control by N-methyl-D-aspartate and kainate of striatal dopamine releasein vivo: a trans-striatal dialysis study. J Neurochem 51: 462–468
Castro SL, Sved AF, Zigmond MJ (1996) Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids.J Neurochem 66:824–833
Cheramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986)In vivo presynaptic control of dopamine release in the cat caudate nucleus-II. Facilitory or inhibitory influence of L-glutamate. Neuroscience 19: 1081–1090
Emmi A, Rajabi H, Steward J (1996) Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP. J Neurosci 16: 5216–5224
Giorguieff MF, Kernel ML, Glowinski J (1977) Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci Lett 6: 73–77
Jhamandas K, Marien M (1987) Glutamate-evoked release of endogenous brain dopamine: inhibition by excitatory amino acid antagonist and an enkephalin analogue. Br J Pharmacol 90: 641–650
Kapatos G, Zigmond MJ (1979) Regulation of dopamine synthesis in striatal synaptosomes during depolarization. Brain Res 170: 299–312
Karreman M, Westerink BH, Moghaddam B (1996) Excitatory amino acid receptors in the ventral tegmental areas regulate dopamine release in the ventral striatum. J Neurochem 67: 601–607
Keefe KA, Zigmond MJ, Abercrombie ED (1992) Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47: 325–332
Keefe KA, Zigmond, MJ, Abercrombie ED (1993) Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J Neurochem 61: 1943–1952
Lonart G, Zigmond MJ (1991) High glutamate concentrations evoke Ca++-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J Pharmacol Exp Ther 256: 1132–1138
Taber MT, Fibiger HC (1997) Feeding-evoked dopamine release in the nucleus accumbens: regulation by glutamatergic mechanisms. Neuroscience 76: 1105–1112
Westerink BHC, DeVries JB, Duran R (1990) Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. J Neurochem 54: 381–387
Westerink BH, Santiago M, DeVries JB (1992) The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn-Schmiederbergs Arch Pharmacol 345: 523–529
Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1993) Compensatory responses to partial loss of dopaminergic neurons: studies with 6-hydroxydopamine. In: Schneider JS, M Gupta (eds) Current concepts in Parkinson's disease research. Hogrefe & Huber, Toronto, pp 99–140
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zigmond, M.J., Castro, S.L., Keefe, K.A. et al. Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum. Amino Acids 14, 57–62 (1998). https://doi.org/10.1007/BF01345243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01345243